Fruquintinib Combined With PD-1 Inhibitor as First-line Maintenance Therapy for Advanced Gastric Cancer

Clinical trial NCT06888037 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06888037
Sponsor: Ruijin Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Gastric Adenocarcinoma GEJ Adenocarcinoma First-line Therapy Maintenance Therapy Fruquintinib PD-1

Start date: 2025-03-31
Primary completion: 2028-03-31
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.